e-learning
resources
Virtual 2021
06.09.2021
Pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impact on in-hospital mortality of Ceftaroline versus standard of care in Community-Acquired Pneumonia: A Propensity Matched Analysis
C. Cilloniz Campos (Barcelona, Spain), R. Mendez (Valencia, Spain), H. Peroni (Buenos Aires, Argentina), C. Garcia-Vidal (Barcelona, Spain), V. Rico (Barcelona, Spain), R. Menendez (Barcelona, Spain), A. Torres (Barcelona, Spain), A. Soriano (Barcelona, Spain)
Source:
Virtual Congress 2021 – Pneumonia
Session:
Pneumonia
Session type:
E-poster
Number:
1753
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Cilloniz Campos (Barcelona, Spain), R. Mendez (Valencia, Spain), H. Peroni (Buenos Aires, Argentina), C. Garcia-Vidal (Barcelona, Spain), V. Rico (Barcelona, Spain), R. Menendez (Barcelona, Spain), A. Torres (Barcelona, Spain), A. Soriano (Barcelona, Spain). Impact on in-hospital mortality of Ceftaroline versus standard of care in Community-Acquired Pneumonia: A Propensity Matched Analysis. 1753
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Twenty-year Trend in Mortality among Hospitalized Patients with Pneumococcal Community-Acquired Pneumonia
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018
Outcome of failed empirical antibiotic therapy on the mortality of elderly patients with hospitalized pneumonia: A propensity score-based analysis
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013
Quick Sepsis-related Organ Failure Assessment to predict ICU admission and mortality in community-acquired pneumonia
Source: International Congress 2017 – Hospital-acquired infections: from prevention to treatment
Year: 2017
Birmingham Community Acquired Pneumonia Severity score (BCAPS) is a better predictor of mortality than CURB65 in hospitalised patients with community acquired pneumonia
Source: Virtual Congress 2020 – Clinical challenges in pneumonia
Year: 2020
Clinical Efficacy and Cost-Effectiveness Analysis of Cefepime or Piperacillin/tazobactam both with Ciprofloxacin in MICU Patients with Severe Pneumonia
Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment
Year: 2019
COPD - Impact on Mortality in Locals with and without Specific Medication
Source: Virtual Congress 2021 – Lung disease burden and management
Year: 2021
SOFA (Sequential Organ Failure Assessment) Score As A Predictor Of Moartality In Ventilated Patients With Multi-drug Resistant Bacteremia
Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 1
Year: 2020
Late Breaking Abstract - Dynamic Early Warning Score versus National Early Warning Score-2 for predicting death or intensive care unit admission in respiratory patients
Source: Virtual Congress 2021 – E-health for COVID-19
Year: 2021
Predictors of 30-day mortality in elderly patients with community acquired pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015
Early Prediction of Extubation Failure in Severe Pneumonia: A Retrospective Cohort Study
Source: International Congress 2019 – COPD and other specific entities in intensive care unit medicine
Year: 2019
Time to Blood Culture Positivity as a Predictor of Clinical Outcomes and Severity in Adults with Bacteremic Pneumococcal Pneumonia
Source: International Congress 2017 – Update on community acquired pneumonia
Year: 2017
Prognostic power of biomarkers to predict in-hospital and postdischarge mortality in community acquired pneumonia
Source: Annual Congress 2013 –A modern approach to lung diseases: from bronchi to pleura
Year: 2013
Validity of APACHE II and SOFA score in Predicting Prognosis in Mechanically Ventilated Patients in Respiratory ICU
Source: Virtual Congress 2021 – Acute non-invasive respiratory therapies in COVID-19 and beyond
Year: 2021
Thirty-Day Readmission Among Patients With Non-Ventilator Hospital Acquired Pneumonia and Effects on Outcomes.
Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment
Year: 2019
Early Rehospitalizations for Pneumonia: Incidence and Predictors in an Italian population-based cohort study
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019
Meta-analysis on the Effect of Current Smoking on the Risk of Developing Community Acquired Pneumonia
Source: International Congress 2018 – Systematic reviews on the health effects of emerging tobacco products and electronic nicotine delivery systems (ENDS)
Year: 2018
Performance of early warning score and CURB-65 in predicting severe outcome in community-acquired pneumonia
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
Role of procalcitonin in predicting severity and in-hospital mortality in patients with community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016
Clinical impact of a prediction score for drug-resistance in community-onset pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Relation between the empiric initial therapy of
S.pneumoniae
community-acquired pneumonia (SP-CAP) and mortality in thirty days of outcome. On behalf of Pneumococcal Pneumonia Cooperative Study Group, Grupo TIR, SEPAR
Source: Annual Congress 2003 - New aspects of community acquired pneumonia
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept